A Multi-Center Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Body Composition and Metabolic Parameters With Diet and Exercise in Conjunction With Treatment With 12.5 mg or 25 mg Enclomiphene
Clinical trial NCT02651688 · COMPLETED
Trial details
- NCT number
- NCT02651688
- Sponsor
- Repros Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-11
- Primary completion
- 2017-05-02
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.